TWD 46.5
(-1.06%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 152.07 Million TWD | -30.61% |
2022 | 219.15 Million TWD | -52.84% |
2021 | 464.7 Million TWD | -9.18% |
2020 | 511.66 Million TWD | -7.07% |
2019 | 550.61 Million TWD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 268.29 Million TWD | 28.45% |
2024 Q1 | 208.87 Million TWD | 37.34% |
2023 Q4 | 152.07 Million TWD | -32.95% |
2023 FY | 152.07 Million TWD | -30.61% |
2023 Q3 | 226.8 Million TWD | 6.91% |
2023 Q2 | 212.13 Million TWD | 3.35% |
2023 Q1 | 205.26 Million TWD | -6.34% |
2022 Q3 | 187.68 Million TWD | 0.0% |
2022 FY | 219.15 Million TWD | -52.84% |
2022 Q4 | 219.15 Million TWD | 16.77% |
2021 FY | 464.7 Million TWD | -9.18% |
2020 FY | 511.66 Million TWD | -7.07% |
2019 FY | - TWD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Allied Biotech Corporation | 796.6 Million TWD | 80.909% |
Easywell Biomedicals, Inc. | 386.34 Million TWD | 60.636% |
TTY Biopharm Company Limited | 1.91 Billion TWD | 92.059% |
Synmosa Biopharma Corporation | 2.43 Billion TWD | 93.767% |
Orient EuroPharma Co., Ltd. | 4.84 Billion TWD | 96.859% |
Center Laboratories, Inc. | 5.62 Billion TWD | 97.296% |
Tien Liang BioTech Co., Ltd. | 84.65 Million TWD | -79.637% |
Orient Pharma Co., Ltd. | 716.92 Million TWD | 78.787% |
InnoPharmax Inc. | 21.49 Million TWD | -607.377% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 160.83 Million TWD | 5.442% |
Excelsior Biopharma Inc. | 377.4 Million TWD | 59.704% |
DV Biomed Co., Ltd. | 387.69 Million TWD | 60.774% |
Foresee Pharmaceuticals Co., Ltd. | 228.25 Million TWD | 33.374% |
Handa Pharmaceuticals, Inc. | 13.24 Million TWD | -1048.633% |
UniPharma Co., Ltd. | 277 Thousand TWD | -54802.166% |
Anxo Pharmaceutical Co., Ltd. | 787.84 Million TWD | 80.697% |
Alar Pharmaceuticals Inc. | 1.4 Million TWD | -10693.4% |
Winston Medical Supply Co., Ltd. | 107.32 Million TWD | -41.694% |
Mercury Biopharmaceutical Corporation | 42.34 Million TWD | -259.109% |
Bioray Biotech Co., Ltd | 69.79 Million TWD | -117.903% |
TSH Biopharm Corporation Limited | 7.84 Million TWD | -1839.041% |